Company / strategic investorRegistered location :8952 Schlieren

Cytos Biotechnology AGDeclared Swiss shareholdings

Cytos Biotechnology AG: 1 Swiss companies with a declared holding, including Kuros Biosciences AG. Latest filing: 14.05.2015.

Disclosure tracking · company alerts with Pro
Estimated value (CHF)
…
Swiss companies held
1
Largest position
1,95 %
Kuros Biosciences AG
12-month trend
Not determinable
0 rate rises · 0 rate falls
Latest filing
14.05.2015
Active since 2008

Declared Swiss portfolio

Latest declared rate per company

Sector allocation

Share of companies held
How to read these figures?

Rates come from the 14 official filings published by SIX Exchange Regulation. A filing is only required when a threshold is crossed (3, 5, 10, 15, 20, 25, 33⅓, 50, 66⅔%): the actual position may have changed since.

Estimated value = shares held per the latest filing × latest CHF closing price. It is an indicative order of magnitude: the position may have changed without a new threshold being crossed, and holdings without a share count or a CHF price are not valued. Each company's mini-chart traces the successive declared rates.

This profile shows only what the declarant published. No external data is added to it.

Disclosure behaviour

Upward and downward threshold crossings show direction, without measuring daily trades below legal thresholds.

90 days · Upward crossings

0

visible history: 3

90 days · Downward crossings

0

visible history: 7

First disclosure: 30.01.2008Last disclosure: 14.05.2015

Nature of disclosed positions

Derivatives, sale positions or lending may indicate a more complex strategy than a long equity holding.

Equity holdings
2
Rights / derivatives
9
Sale positions
20

Latest shareholding disclosures

insider24.ch

Follow Cytos Biotechnology AG’s disclosures

Find new disclosures in your watchlist. With Pro, receive email and Telegram alerts for your chosen companies.

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open

Management purchases in this portfolio

Loading activity…

    These figures aggregate public disclosures. They are not investment advice.

    Common questions

    Which Swiss companies are in Cytos Biotechnology AG’s disclosed portfolio?

    Kuros Biosciences AG.

    What is Cytos Biotechnology AG’s latest disclosure?

    The latest available disclosure was published on 14.05.2015 and concerns Kuros Biosciences AG. Threshold disclosures do not describe every purchase or sale.

    Explore further

    Recent insider purchases

    What are insiders doing at companies disclosed by this shareholder?

    All purchases this week

    Insider barometer

    Compare insider purchases and sales across the Swiss stock exchange over 30 days.

    View the Swiss barometer

    These signals are not investment advice.